Evidence summaries for each of the standards were generated by using several approaches. First, where available, existing systematic reviews (only English language) on all aspects of tuberculosis diagnosis and treatment were identified by a comprehensive search of PubMed and the Cochrane Library (both searches were up to date as of January, 2006). Second, existing evidence-based tuberculosis guidelines and recommendations were identified and compiled (a list of all the tuberculosis
ReviewInternational Standards for Tuberculosis Care
Introduction
In the past decade there has been substantial progress in the development and implementation of the strategies necessary for effective tuberculosis control. However, the disease remains an enormous and growing global health problem.1, 2, 3 Part of the reason for failing to achieve a more rapid reduction in tuberculosis incidence—even though the means to do so are well established, widely available, and embodied in the internationally recommended directly observed treatment, short course (DOTS) strategy—is the lack of involvement of practitioners outside of public-health tuberculosis control programmes in the provision of high quality tuberculosis care, in coordination with local and national control programmes.
Studies of the performance of the private sector conducted in different parts of the world suggest that poor quality care is common.4, 5, 6, 7, 8, 9, 10, 11, 12, 13 Clinicians—in particular those who work in the private health-care sector—often deviate from standard, internationally recommended, tuberculosis management practices.11, 13 These deviations include under-use of sputum smear microscopy for diagnosis (figure 1), generally associated with over-reliance on radiography; use of non-recommended drug regimens with incorrect combinations of drugs; mistakes in both drug dose and duration of treatment; and failure to supervise and assure adherence to treatment.5, 6, 7, 8, 9, 10, 11, 12, 13
Full engagement of all care providers through various forms of public–private and public–public partnerships is an important component of both WHO's expanded strategy for tuberculosis control,14 and the Global Plan to Stop TB, 2006–2015.15 Although there have been several approaches developed for involvement of the private sector (as well as for government employed providers who are not affiliated with a tuberculosis control programme), there has been no generally agreed upon set of standards describing the essential actions that should be taken by all practitioners in providing tuberculosis services. To address this shortcoming, the International Standards for Tuberculosis Care (ISTC; panel 1)16 were developed through a year-long inclusive process guided by a 28-member steering committee. The steering committee included individuals who represented a wide variety of relevant perspectives on tuberculosis care and control (see listing at the end of the paper). In addition, the document was presented at various public forums with an open invitation for comments. Several individuals and organisations had substantive comments, all of which were considered seriously, although not all were included in the document. It should be noted that in tandem with the development of the ISTC, a group of patient activists and advocates developed the Patients' Charter for Tuberculosis Care,17 describing patients' rights and responsibilities. There was considerable interaction between the two groups during the course of drafting the documents.
The purpose of ISTC is to describe a widely endorsed (an up-to-date list of endorsers can be found at http://www.stoptb.org) level of care that all practitioners, public and private, should seek to achieve in managing patients who have, or are suspected of having, tuberculosis. The ISTC differ from existing guidelines in that they describe what should be done, whereas guidelines describe how the action is to be accomplished. The ISTC are not intended to replace either WHO or local guidelines and were written to accommodate local differences in practice. The main target audience for the ISTC is the broad group of health-care professionals who provide diagnostic and treatment services for tuberculosis outside of government tuberculosis programmes.
It is anticipated that the ISTC will be used as a tool to unify approaches to tuberculosis care between public (at least government tuberculosis control programmes) and private providers. Although the standards themselves should not be modified based on local circumstances, clearly there will need to be local approaches to their use and implementation. Professional medical societies are very influential in many countries, and can serve as a conduit through which the standards can be disseminated. Moreover, professional societies can serve to exert peer pressure both on their members and, when necessary, on government programmes to adhere to the ISTC. Another anticipated use of the ISTC is to serve as a focus of curricula for medical, nursing, and allied health students as well as for in-service education. There are many elements that are necessary for tuberculosis care and control to be optimally effective. These include patient and community awareness, engagement and mobilisation; access to care; availability of quality assured laboratories; appropriate information systems; and adequate primary services and health systems in general.14 Although these elements are of substantial importance, they are beyond the scope of this set of standards, but are addressed in several other documents, particularly by the new Stop TB Strategy.14 We anticipate that as new information emerges these standards will change. The ISTC are envisioned as a living document that will be undergoing regular review and revision.
The ISTC apply to patients of all ages, including those with smear-positive, smear-negative, and extra-pulmonary tuberculosis, tuberculosis caused by drug-resistant Mycobacterium tuberculosis complex organisms, and tuberculosis combined with HIV infection. A high standard of care is essential for all forms of tuberculosis to restore the health of individuals, to prevent the disease in their families and others with whom they come into contact, and to protect the health of communities.4 The ISTC focus on the contribution that good clinical care of individual patients with, or suspected of having, tuberculosis can make to population-based tuberculosis control. A balanced approach emphasising both individual patient care and public-health principles of disease control is essential to reduce the effects on human health and economic losses caused by tuberculosis.
The basic principles of care for people with, or suspected of having, tuberculosis are the same worldwide: a diagnosis should be established promptly and accurately; standardised treatment regimens of proven efficacy should be used, together with appropriate treatment support and supervision; the response to treatment should be monitored; and the essential public-health responsibilities must be carried out. Prompt and accurate diagnosis and effective treatment are not only essential for good patient care, they are also the key elements in the public-health response to tuberculosis. Thus, all providers who undertake evaluation and treatment of patients with tuberculosis must recognise that as well as delivering care to an individual, they are also assuming an important public-health function that entails a high level of responsibility to the community, as well as to the individual patient.
Section snippets
Standard 1
All persons with otherwise unexplained productive cough lasting 2–3 weeks or more should be evaluated for tuberculosis.
Standard 7
Any practitioner treating a patient for tuberculosis is assuming an important public-health responsibility. To fulfil this responsibility the practitioner must not only prescribe an appropriate regimen, but also be capable of assessing the adherence of the patient to the regimen and addressing poor adherence when it occurs. By so doing the provider will be able to ensure adherence to the regimen until treatment is completed.
Standard 16
All providers of care for patients with tuberculosis should ensure that people (especially children under 5 years of age and those with HIV infection) who are in close contact with patients who have infectious tuberculosis are evaluated and managed in line with international recommendations. Children under 5 years of age and people with HIV infection who have been in contact with an infectious case should be evaluated for both latent infection with M tuberculosis and for active tuberculosis.
Search strategy and selection criteria
References (121)
- et al.
Private practitioners and public health: weak links in tuberculosis control
Lancet
(2001) - et al.
Treatment of tuberculosis by private general practitioners in India
Tubercle
(1991) - et al.
WHO's new Stop TB Strategy
Lancet
(2006) - et al.
Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review
Lancet Infect Dis
(2006) - et al.
Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review
Lancet Infect Dis
(2006) - et al.
Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence
Lancet Infect Dis
(2003) - et al.
Diagnosing tuberculosis in a resource-poor setting: the value of a trial of antibiotics
Trans R Soc Trop Med Hyg
(1997) - et al.
Diagnostic accuracy of nucleic acid amplification tests for tuberculous meningitis: a systematic review and meta-analysis
Lancet Infect Dis
(2003) - et al.
Diagnosis and treatment of tuberculosis in children
Lancet Infect Dis
(2003) - et al.
The challenge of diagnosing tuberculosis in children: a perspective from a high incidence area
Paediatr Respir Rev
(2004)
Tuberculosis in children: considerations for children from developing countries
Semin Pediatr Infect Dis
Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial
Lancet
Directly observed therapy for tuberculosis given twice weekly in the workplace in urban South Africa
Trans R Soc Trop Med Hyg
Directly observed therapy and treatment adherence
Lancet
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic
Arch Intern Med
The evolution of tuberculosis control, and prospects for reaching the millennium development goals
JAMA
Tuberculosis, vulnerability, and access to quality care
JAMA
Delay and discontinuity—a survey of TB patients' search of a diagnosis in a diversified health care system
Int J Tuberc Lung Dis
A survey of prescribing patterns for tuberculosis treatment amongst doctors in a Bolivian city
Int J Tuberc Lung Dis
Diagnostic evaluation of pulmonary tuberculosis: what do doctors of modern medicine do in India?
Int J Tuberc Lung Dis
Do private doctors follow national guidelines for managing pulmonary tuberculosis in Pakistan?
East Mediterr Health J
Survey of knowledge, attitudes and practices for tuberculosis among general practitioners in Delhi, India
Int J Tuberc Lung Dis
Do doctors in north-western Somalia follow the national guidelines for tuberculosis management?
East Mediterr Health J
The Global Plan to Stop TB 2006–2015
International Standards for Tuberculosis Care
Patients' Charter for Tuberculosis Care
Respiratory care in primary care services: a survey in 9 countries
What is the role of sputum microscopy in patients attending health facilities?
Control de Tuberculosis en America Latina: Manual de Normas y Procedimientos para programas Integrados
Comparison of cough of 2 and 3 weeks to improve detection of smear-positive tuberculosis cases among out-patients in India
Int J Tuberc Lung Dis
Tuberculosis diagnosis and treatment practices of private physicians in Karachi, Pakistan
East Mediterr Health J
Yield of serial sputum smear examinations in the evaluation of pulmonary tuberculosis: a systematic review
A method to determine the utility of the third diagnostic and the second follow-up sputum smear examinations to diagnose tuberculosis cases and failures
Int J Tuberc Lung Dis
Smear examination of two specimens for diagnosis of pulmonary tuberculosis in Tiruvallur District, south India
Int J Tuberc Lung Dis
Optimal tuberculosis case detection by direct sputum smear microscopy: how much better is more?
Int J Tuberc Lung Dis
Diagnosis of tuberculosis under RNTCP: examination of two or three sputum specimens
Indian J Tuberc
High rates of clinical and subclinical tuberculosis among HIV-infected ambulatory subjects in Tanzania
Clin Infect Dis
How reliable is chest radiography?
What are the relative merits of chest radiography and sputum examination (smear microscopy and culture) in case detection among new outpatients with prolonged chest symptoms?
Diagnostic photofluorography and sputum microscopy in tuberculosis case findings. Proceedings of the 9th Eastern Region Tuberculosis Conference and 29th National Conference on Tuberculosis and Chest Diseases
A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis
Int J Tuberc Lung Dis
Useful clues to the presence of smear-negative pulmonary tuberculosis in a West African city
Int J Tuberc Lung Dis
Non-response to antibiotics predicts tuberculosis in AFB-smear-negative TB suspects, Botswana, 1997–1999
Int J Tuberc Lung Dis
Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania
Int J Tuberc Lung Dis
The WHO/IUATLD diagnostic algorithm for tuberculosis and empiric fluoroquinolone use: potential pitfalls
Int J Tuberc Lung Dis
What is the role of mycobacterial culture in diagnosis and case finding?
Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment
Am Rev Respir Dis
What is the current and potential role of diagnostic tests other than sputum microscopy and culture?
Cited by (295)
The Rv3874-Rv3875 chimeric protein shows a promiscuous serodiagnostic potential for tuberculosis
2022, TuberculosisCitation Excerpt :All these practices also met the criteria given in the Declaration of Geneva for patient care. Antisera for Rv3874 and Rv3875 were produced in Rabbits according to the previously described protocol [25]. In short, native antigens at 600 μg/500μl in 1X Phosphate buffer saline were mixed with 300 μl of Freund's Complete Adjuvant (FCA).
Unconstrained one-stage total knee arthroplasty PS design in patient with secondary osteoarthritis due to granulomatous infection with medial femoral condyle defect: A case report
2022, International Journal of Surgery Case ReportsSputum smear non-conversion among adult persons with bacteriologically confirmed pulmonary tuberculosis in rural eastern Uganda
2020, Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesCitation Excerpt :The proportion of persons with BC-PTB who were sputum smear non-converters at two months of TB treatment is small. Since not all persons with BC-PTB achieve SSC by two months of treatment, drug susceptibility testing using GeneXpert remains critical in ruling out possible MDR-TB in sputum smear non-converters as recommended [3]. This study shows that higher baseline MTB load is associated with increased likelihood of sputum smear non-conversion, consistent with several studies [13,24–28].
Tuberculosis: a focused review for the emergency medicine clinician
2020, American Journal of Emergency Medicine